Medicare Enrolled

Dr. Krzysztof Rosadzinski, M.D.

Medical Specialty Clinic/Center · Hyannis, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1030 FALMOUTH RD, Hyannis, MA 02601
7744705080
Registered in NPPES since 2012
NPI: 1538415526 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosadzinski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosadzinski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosadzinski

Dr. Krzysztof Rosadzinski is a medical specialty clinic/center specialist in Hyannis, MA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Rosadzinski performed 8,725 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Rosadzinski received a total of $7,130 from 42 pharmaceutical and/or device companies across 368 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosadzinski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years of NPI registration ▲ 8,725 Medicare services $7,130 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
8,725
Medicare services
1.0× state median for medical specialty clinic/center
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 6,600 $18 $39
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,090 $95 $318
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
409 $65 $225
Injection, methylprednisolone acetate, 40 mg 176 $5 $16
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
122 $10 $43
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
105 $139 $445
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
77 $61 $192
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
54 $120 $433
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
28 $51 $175
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
20 $26 $142
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
15 $47 $153
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
15 $61 $224
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $42 $142
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,130
Total received (2018-2024)
Avg $1,019/year across 7 years
Top 0% in MA for medical specialty clinic/center
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
368
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,292
2023
$1,013
2022
$272
2021
$134
2020
$267
2019
$1,954
2018
$1,198

Payments by company (2024)

Amgen Inc.
$528
ABBVIE INC.
$496
UCB, Inc.
$199
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
AstraZeneca Pharmaceuticals LP
$168
Janssen Biotech, Inc.
$116
PFIZER INC.
$94
GlaxoSmithKline, LLC.
$84
Fresenius Kabi USA, LLC
$80
GENZYME CORPORATION
$78
Sandoz Inc.
$66
Lilly USA, LLC
$51
E.R. Squibb & Sons, L.L.C.
$47
Organon Llc
$47
Novartis Pharmaceuticals Corporation
$43
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 53.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,094
ABBVIE INC.
$704
Janssen Biotech, Inc.
$484
AbbVie Inc.
$402
Lilly USA, LLC
$392
UCB, Inc.
$383
AbbVie, Inc.
$338
AstraZeneca Pharmaceuticals LP
$309
PFIZER INC.
$273
Novartis Pharmaceuticals Corporation
$253
Boehringer Ingelheim Pharmaceuticals, Inc.
$247
Genentech USA, Inc.
$226
E.R. Squibb & Sons, L.L.C.
$192
Novo Nordisk Inc
$181
GlaxoSmithKline, LLC.
$173
Celgene Corporation
$165
Fresenius Kabi USA, LLC
$155
Sobi, Inc
$137
GENZYME CORPORATION
$124
W. L. Gore & Associates, Inc.
$102
Cardiovascular Systems Inc.
$84
Corcept Therapeutics
$74
Alexion Pharmaceuticals, Inc.
$67
Ipsen Biopharmaceuticals, Inc
$67
Sandoz Inc.
$66
MEDEXUS PHARMA, INC.
$61
Organon Llc
$47
Genentech, Inc.
$38
Horizon Pharma plc
$31
Tandem Diabetes Care, Inc.
$28
Shire North American Group Inc
$28
Regeneron Healthcare Solutions, Inc.
$27
Flexion Therapeutics, Inc.
$25
SOBI, INC
$20
Bioventus LLC
$20
Valeritas, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Radius Health, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$15
Merck Sharp & Dohme Corporation
$15
Ultragenyx Pharmaceutical Inc.
$14
FIDIA PHARMA USA INC.
$12
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Cryvista · Durolane · EVENITY · EXCLUDER AAA Endoprosthesis · Enbrel · FARXIGA · FORTEO · HADLIMA · HUMIRA · HYALGAN · HYRIMOZ · Humira · IDACIO · JANUVIA · JARDIANCE · KEVZARA · KINERET · KRYSTEXXA · Kerendia · Kineret · Korlym · NATPARA (PARATHYROID HORMONE) · NUCALA · OFEV · ORENCIA · Otezla · Ozempic · Peripheral Orbital Atherectomy System · Prolia · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIQUA · SOLIRIS · SOMATULINE DEPOT · STRENSIQ · Saxenda · Somatuline Depot · TALTZ · TAVNEOS · TREMFYA · Tyenne · Tymlos · ULTOMIRIS · V-GO · XELJANZ · Zilretta · t-slim insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a medical specialty clinic/center specialist in Hyannis?
Compare medical specialty clinic/centers in the Hyannis area by procedure volume, costs, and industry payment transparency.
Browse medical specialty clinic/centers nearby

Geographic Context

Medical specialty clinic/centers in nearby ZIP areas
1
County median income
$94,452
Nearest hospital to ZIP centroid (approximate)
CAPE COD HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rosadzinski is a clinical cardiology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rosadzinski experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rosadzinski performed 6,600 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rosadzinski receive payments from pharmaceutical companies?
Yes. Dr. Rosadzinski received a total of $7,130 from 42 companies across 368 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosadzinski's costs compare to other medical specialty clinic/centers in Hyannis?
Dr. Rosadzinski's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosadzinski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →